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INTRODUC T IOU

"It is difficult to keep one's footing in a stampede and practically impossible to think or plan
connectedly in a panic. Therefore, the members of the
medical profession as well as the public, who have
been caught in the whirlwind sweep of this new medical advance, have lost all sense of proportion,
direction and balance whenever the subject of endocrinology is touched on. In spite of the turmoil,
real progress can be recorded, often unheard, because of incoherent babble and ballyhoo, which is
more vocal than constructive and conservative advances • 11

(

33)

In this turmoil of activity there is a growing
sense of doubt as to the efficacy of many so-called
hormonal preparations, and an increasing suspicion on
the part of many that therapeutic use of certain hormones may not only be without demonstrable effect in
the course of the condition for which they are administered, but also be distinctly harmful to the patient.
Such a state of doubt has recently arisen in regard to the administration of the ovarian follicular
hormone or of any of its derivatives, and several warnings advising against promiscuous use of such estrogenic principles have recently appeared editorially in
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medical journals. (23, 30). There seems to be a definite theoretical and experimental basis for the apprehension expressed, as it has been recognized for many
years that during pregnancy (when physiologically there
is increased production of estrogenic hormone) the
growth rate of a breast cancer is increased.
Many experiments on mice will be thoroughly discussed later which seem

to show a definite carcinogen-

ic effect from estrogenic principle.
This paper, therefore, will

~.ttempt

to clarify the

situation, to analyze the merits of the work already
done, to point out deficiencies in the present knowledge,
and to conclude in so far as is possible at this time,.
whether actual danger threatens the patient treated with
sex hormones.

I

PHYSIOLOGICAL BACKGROUlID

"The endocrine origin of breast tumors rests on
the hypothesis that the stimuli to normal growth
when active in increased intensity or applied over
excessive or irregular periods of time, may result
in atypical forms of proliferation. For that reason
the facts of the hormone physiology of the normal
mammary gland are of basic importance in the study
of breast neoplasma." (70)
It is, therefore, important to review the part
played by estrogenic hormones in the physiology of the
breast. There has been some discussion over the exact
nature of this relationship, but the generally accepted view as presented in most textbooks of physiology
and endocrinology will be considered.
Wiggers (76) in describing the development of the
mammary glands stated:
"The mammary glands undergo no marked changes from
birth to adolescence. During prepubescence and puberty, and correlated with the accelerated development of the ovaries a considerable enlargement occurs in the female. This consists essentially of an
extensive development of the duct system including
the nipples; but the glandular alveoli develop but
little. The association with ovulation suggests

r
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that the estrogenic hormones of the ovary may be
concerned and this has been made more certain by
the demonstration that injections of theelin stimulate proliferation in immature animals and in
castrated males as well as females. From this
state of pubertal development no further change
occurs unless pregnancy supervenes."
During the first half of pregnancy there is rather
marked alveolar hyperplasia while during the latter half
there is secretory awakening and hypertrophy of the alveoli. The evidence of many investigations has indicated
that such preparation is due to an associated action of
theelin and progestin (Wiggers, 76).
According to Edgar Allen (2) the simulfaneous action
of theelin and progestin has been found necessary to produce complete mammary growth in animals other than the
guinea pig.
Wiggers (76) asserted that injection of progestin
alone does not produce proliferation of secreting epithelium in spayed rabbits, but that simultaneous injection of theelin and progestin does.
The problem, however, is not so simple as this may
suggest. Subsequent work has shown that anterior pituitary substance likewise leads to similar proliferation
and hypertrophy. However, such an effect may be consid-
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ered to be either direct, by action on the breast tissue itself, or indirect, by action on the ovary causing the production of theelin and progestin as it is
known to do.
Wiggers dealt with this phase of the problem and
concluded that species differences undoubtedly exist.
In the rabbit, anterior pituitary factor seems to be
effective in the absence of ovaries, while in the guinea pig and rat ovarian factors must be present. The
effects of anterior pituitary hormone also seem to depend on the preceding degree of development of the
mammary glands; it being generally conceded that pituitary factors cannot be expected to exert any action
on wholly undeveloped glandular tissue.
Work of investigators has generally borne out
these statements, and in support thereof stands Edgar
Allen (2) who st~ted in part:
"The growth of the ma.mma.ry gland is primarily dependent on the estrogenic hormones. The .Primary
ducts of the rudimentary mammary glands of males
have been found to respond to both theelin and
theelol. At the present time the guinea pig is the
only species extensively investigated in which a
complete growth of the mammary gla.nds (both ducts
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and alveoli) may be

induced by theelin. The simul-

taneous action of theelin and progestin has been
found necessary to

p~oduce

complete mammary growth

in other animals so far studied."
His statements were amplified further to the effect that:
"a development of small localized lobules of alveoli in addition to the ducts has been observed in
the mammary glands of male mice of an inbred strain
following injections of theelin over a long period".
He interpreted

~his

finding to be indicative

that

localized areas of the experimentally grown mammary
ducts may be more sensitive to stimulation with theelin.
In the light of what is to follow this observation is
of considerable importance.
Turner and others (74) confirmed the finding that
theelin and theelol are capable of stimulating the growth
of the duct system of the mammary gland of the rabbit,
rat and mouse, and Evans (25) in writing about recent advances in physiology summarized the work done on this
subject in very nearly the same manner as did Wiggers.
Thus is described the effect of endocrines on the
breast --- so far as physiologic effects are involved.

7
SUMMARY

1) Theelin or theelol is capable of producing marked
proliferation of the duct system in the mammary
gland.
2) Progestin (corpus luteum hormone) alone has no effect, but coupled with theelin it produces alveolar
hyperplasia as well as extension of the ducts.
3) Only in the guinea pig can theelin alone produce
the development of both ducts and alveoli, while in
the rabbit, rat and mouse, the combined action of
theelin and progestin is required.
4) Allen, however, describes localized areas of alveolar hyperplasia in the mammary gland of the mouse
following prolonged injections of theelin. This he
interprets as indicative of greater sensitivity to
theelin.
5) Anterior pituitary hormones effect breast development only by indirect action on the ovary (except
in the rabbit), but the lactogenic hormone produces
lactation in a previously developed breast.
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STUDIES ON EXPERIMENTAL A.~IMAI.S

Experimental attack upon the pathogenic effects of
the female sex hormone upon the breast has followed
essentially along three lines.
The first of these was the finding that tar applied
to the skin over long periods of time may induce carcinoma. This led to the isolation of certain chemical substances from coal tar showing similar carcinogenic effect. These substances have since been synthesized.
The second line of investigation began with the
analysis of the mechanism underlying the sexual cycle.
It proceeded to study the place .of origin, the function,
and the chemical constitution of the hormones dominating in various phases of the cycle.
The third line of investigation

~egan

with a study

of the significance of ovarian hormones in the development of mrumnary cancer in mice.
It was not long after the synthesis of the carcinogenic substances present in coal tar before a chemical
similarity was found between these substances and the
sex hormones, and Kenna.way, Cook and Dodds (according
to Loeb, 53) showed that certain of these chemical
substances with carcinogenic effect were also capable
of producing estrus in the experimental mice.

9

Further experiments to be described at greater
length have shown that "estrogenic hormones are factors
in the development of certain kinds of cancer". {Loeb,
53).
I. COAL TAR PRODUCTS AJID CANCER

The first series of experiments began with the
finding by Yamigawa and Ichikawa in 1915 {79) that long
continued applications of tar to the ear skin of rabbits
may initiate cancerous changes in the tissue thus exposed to the action of this substance.
Tsutsui {73) in 1918 extended this work by showing
that in mice epidermal cancer can be produced in a considerably larger percentage of cases than in rabbits.
He thus established the mouse as the more favorable
species for testing the carcino:?genic power of various
substances related to or derived from tar.
Chemical studies by Bloch and Dreifuss (6) next
revealed that the compounds present in tar and responsible for the production of cancer are neutral, nitrogenfree substances possessing a high boiling point. This
finding led to attempts to isolate the active principles
involved.
It has since been found that if isoprene is exposed to a high temperature in an atmosphere of hydrogen, a mixture of compounds, chiefly aromatic in nature,
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develops. This mixture was found to have marked carcinogenic power.
Similarly carcinogenic substances were also produced by exposing acetylene and also yeast and human
skin to very high temperatures (Loeb, 53).
Numerous investigators during the past decade
have isolated pure substances from such mixtures and
indeed many of these have been synthesized.
Further chemical investigation has revealed a
basic similarity in structure between the molecules of
these various substances. It has been demonstrated that
it is the cyclo-penteno-phenanthrene nucleus which is
common to all these carcinogenic hydrocarbons (Evans,
25), and that a series of compounds related to 1:2
benza.nthracene, which itself is inactive, possesses
especially marked carcinogenic properties (Loeb., 53).
The statement may therefore be made, in general, that
a molecular structure consisting of rings attached to
the 1:2 and 5:6 positions of the anthracene ring system tends to confer a marked carcinogenic activity.
This series of investigations has revealed, therefore, that insofar as tar and the carcinogenic substances it contains are concerned in the etiology of
cancer, the action is much more specific than had
originally been supposed.
Their action according to Loeb (53) seems to be

11

directly as growth stimulating, as they apparently may
induce cancer formation without first causing a local
irritation. They are not selective as regards the tissue on which they act as they have been· shown to produce tumors of connective tissue origin as well as of
epithelial cells. They effect, step by step, changes
in the cells on which they act, eventually resulting
in the formation of cancer from originally normal
cells.
Evans (25) called attention to the

chemical

closeAsimilar~

ity between the carcinogenic agents already described
and cholesterol. Kennaway and Sampson (40) have obtained from cholesterol heated to about 800° C. products which caused epithelioma of the skin in mice.
Bourne (11) also commented on the close chemical
similarity between the carcinogenic compounds present
in tar and cholesterol --- even to the point of classing these substances with the sterols.
Such a structure he described also as relating
them closely with the male sex hormone (androkynin);
with the female sex hormones (theelin and theelol);
with antirachitic vitamin D; and with the bile acids.
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II. ESTROGENIC SUBSTANClf3 AND C.AlrGER

Among the various agents described above as related to one another chemically it is of particular interest in the present discussion to study what similarities and what differences may exist between the carcinogenic agents in tar and the estrogenic hormone. In
other words it is now in order to study what estrogenic
effect may be produced by the carcinogenic agents of
tar and what if any carcinogenic effect may be ascribed
to estrogenic hormones.
Extensive investigations of these effects have been
undertaken during the past twenty years. As a rule there
has been found no relationship at all between carcinogenic and estrogenic potency. Some of the more potent
carcinogenic agents display weak estrogenic power.
Others display no estrogenic power at all. In this regard it is worthy of note that vitamin D is estrogenic
while so closely related a substance as cholesterol is
not.
It is especially interesting to note that Cramer
and Horning (19) applied estrin in .01% chloroform
twice weekly to the skin of mice in the same manner
that earlier investigators applied tar and its constituent substances. In all of five males thus treated
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carcinoma of the breast developed. The strain of mice
used was one in which the females normally develop carcinoma mammae in large numbers, but in which the males
never develop this type of tumor spontaneously. This
demonstrated a specificity of estrin which is not
possessed by the carcinogenic substances of tar --probably arising from the physiologic specificity of
estrin for the breast tissue.
Burrows (13) also reported carcinoma ma.mmae occurring in two males of one hundred thirty ordinary
mice treated twice weekiy with ketohydroxy estrin in
benzene. He believed this significant because of the
rarity of spontaneous mammary cancer in male mice.
Schockaert {62) in 1935 described an ingenious
experiment in which he treated

three hundred mice

with coal tar in the accepted fashion. To one subgroup
he also gave dihydrofolliculin injections.

~n

this sub-

group tar tumors appeared four weeks earlier than they
did in the controls; they were more numerous (65.2% as
compared with 27.2% in the controls at the end of five
and one-half months); and they grew more rapidly.
He interpret-ed_ this result on the basis of a predisposing and stimulating effect produced by the folliculin. His work has not as yet been corroborated, nor
has it been contradicted.
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Loeb concluded from his study of the facts as they
are known and understood at present that:
"(l) there are substances which are both carcinogenic and estrogenic; {2) there are carcinogenic substances which are not estrogenic; (3) there are estrogenic substances which are not carcinogenic; (4)
even in cases in which substances are both estrogenic
and carcinogenic, there is no parallelism between
the strength of these two activities." (53)

III. MAJAUARY CARCnmMA IN THE MOUSE

The discussion turns now to a very extensive series of experiments dealing with the significance of the
ovarian hormones in the development of mammary cancer
in mice.
In 1911 Lathrop and Loeb (46) described a family
of mice in which the hereditary transmission of a tumor seemed to be apparent.
In 1914 (47) these same investigators described
the results obtained from a series of experiments on the
heredity of tumors in mice. This study was suggested from
the common observation by breeders of mice that there was
a tendency for carcinoma mammae in the mouse to occur in
families. Their findings were, essentially, that there is
a constant incidence of carcinoma mammae in pure strains
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of mice, the incidence varying in different strains;
that the age of development of the tumor tends to be
constant in each strain, but varies in different
strains; and that both these characteristics tend to
recur in succeeding generations.
In a paper written by Slye in 1920 (64) she described the value of inbreeding of mice, not because it
increases the incidence of cancer in mice (or in any
other species), but because it emphasizes the hereditary
makeup of the species or strain under study. Her work
as well as that of many others interested in the ea.me
field has shown that, by inbreeding, strains of mice
may be produced some of which show a high incidence of
mammary cancer and some a very low incidence. The important fact is, however, that she is able to predict
not only what percent of the females will show mammary
carcinoma in a given strain, but also at what age period these tumors will begin to appear.
Given these basic facts as to the normal incidence
of spontaneous breast cancer in mice the next step is
merely to find what procedures other than altering the
strain, will produce changes in this incidence.
EFFECTS OF

PRi~VEN'TIOU

OF BREEDDTG:

Lathrop and Loeb in 1914 (48) brought the attention of cancer research to the finding that in females
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allowed to breed freely there was a considerably higher
incidence of mammary cancer than in mice prevented from
breeding. They also found that in non-breeders the age
before onset of the tumor was greater than it was in
breeders. These facts are entirely independent of the
difference in tumor incidence in varying strains of
mice, although they described the finding that in relatively poor breeders (where this was characteristic of
the strain) the incidence of ma"l'll?lary carcinoma was also
lower. The significance of this finding was recognized
by the authors as of dubious nature.

Bashford in a comrrunication to Lathrop and Loeb
(48) stated that he found no influence of pregnancies
on carcinoma in mice.
Lathrop and Loeb in 1916 (49) described further
experiments which corroborated their previous results.
Maud Slye in 1920 (63) told of her experience
with breeding females. She stated that without exception the amount of tumor grown while reproductive was
much less than during her non-reproductive period, and
that the amount of tumor grown by reproducing females
was much less than that grown by non-reproducing females.
Leo Loeb again in 1919 (51) confirmed this finding
that pregnancy decreases the rate of growth of adeno-

r
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carcinoma of the mouse breast, but reported that breeding is associated with a higher incidence of mammary
carcinoma. Some of his data is quoted in the table
which follows. All of the mice used were of the same
strain.
Mice without tumors
Non-breeders

45

Breeders

32 2/3%

w. s.

1/3%

Mice with tumors
54 2/3%

62

2/3%

Murray in 1927 (59) confirmed Loeb's claims

and stated that enforced non-breeding delays very
markedly the age of tumor appearance and may inhibit
entirely development of carcinoma in mice which would
probably have had a high tumor incidence had they lived
a normal sexual life.
Cori (17) desired to check Loeb's work and found
in 1927 that in his strain of mice, 94% of those females allowed to breed freely developed mammary cancer,
while in non-breeding controls of the same strain only
?8.5% developed tumors.
Thus there seems to be ample evidence to the effect
that prevention of breeding in female mice (1) lowers
the incidence of spontaneous mammary carcinoma and (2)
raises the age before development of the tumor occurs.
During reproduction, also, there seems to be a decrease
in the rate of growth of the tumor.

r
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EFFECTS OF REMOVAL OF THE OVARY:
To further carry out the studies on the relation
between the ovary and the breast it seemed logical to
attempt to find out what would occur in the absence of
the ovary. Accordingly in 1916 Lathrop and Loeb (49)
reported upon the results obtained by castration of
female mice. They found that castration before the age
of six months markedly decreased the incidence of
spontaneous mammary cancer in these mice, and that
when a tumor did develop,

it was at a later age. These

effects were found to be greater than were the similar
effects obtained by prevention of breeding. Castration
after the age of six months was found to have little
or no effect.
The authors claimed this to be the first experimental

de~onstration

of internal secretion as an etio-

logical factor in spontaneous development of cancer.
They described this as a chemical factor superimposed
on an hereditary factor distinct from itself.
In 1919 Loeb (51) re-described the work reported
above with a large volume o,f discussion regarding
theoretical explanations of his findings. This will be
taken up further in subsequent discussion. He concluded
that:
"In case such an influence of internal secretion
should exist it must be a specific one. There is no
reason to assume that removal of an organ with in-
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ternal secretion should influence the development
of cancer in organs the growth of which is not affected by their internal secretion under normal
conditions".
Cori in 1927 (17) amplified Loeb's work by finding that in as high as 15% to 18% of castrated female
mice there was a regeneration of the ovary. To eliminate the effect of this he followed his castrated mice
by the use of vaginal smears to determine absence of
ovarian function. In none of the females castrated before the age of twenty-two days where ovarian regeneration failed to occur did carcinoma develop. Furthermore the castrated mice lived on the average to a
greater age than did either the non-breeding or breeding mice. Consequently in them there was a greater
possibility for carcinoma to develop before they died.
Murray also in 192? (59) compared the effects of
castration and those of non-breeding. He found them to
be very similar. He compared the age of onset of the
tumors as follows:
Breeding females
Non-breeding females
Castrated females

y oum:i:es t

4 mo.
10 mo.
9 mo.

Average

Old es t
9 mo.
14 mo.
14.7 mo. 17 mo.
15.6 mo. 18.8 mo.

It may be concluded then that castration of the
female mouse reduces markedly the incidence of spon-

!

I
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taneous mammary carcinoma.

1·

I

EFFECTS OF OVARIAN TRANSPLANTS IN CASTRATED MALE MICE:
The next step in the case against theelin was the

I

I
'

i

'

attempt to produce mammary carcinoma in the male mouse
where such tumors usually are very rarely seen. This was
carried out by the attempt to transplant ovaries from a
female of the strain to be studied into a male, preferably a litter mate.
Loeb (51) began this type of work in 1919. In his
series of mice there were no mammary tumors developed.
However, he stated that many of the ovarian transplants
failed to grow, and that many more were apparently never
functional.
Murray in 1927 (59) transplanted ovaries into two
hundred ten castrated male mice and in four of these
tumors appeared by the age of ten to thirteen months.
In two hundred forty-one castrated males of the same
strain no tumors developed.
He reported in 1928 (60) that 7.1% of these male
mice with the ovarian transplants developed tumors at
an average age of 14.4 months.
Gardner (34) reported that he failed to find evidence of tumors in any of his series of male mice thus
treated, although he described the development of the

--

---- ---
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male breast to an extent comparable with that in the
normal virgin female.
EFFECTS OF THE

I~tJECTIOU

OF FOLLICULIN:

When Allen and Doisy in 1923 (3) isolated the active principle of the ovarian follicle they furnished
the research workers with a new tool for investigating
the relation of the ovary to mammary cancer. The investigations using ovarian follicular hormone are many,
and only a few of the more important ones can be touched upon in the ensuing paragraphs.
Cori (17) as early as 1927 attempted to produce
mammary tumors by injection of follicular hormone, but
found that none were obtained. He felt that this was
due to the fact that an oily preparation of the hormone
was used and because of reactions to this the treatment
could not be carried out over a sufficiently long period.
Lacassagne (42) obtained the first positive results
in 1934 when he noted that in one family of mice treated by injections of folliculin there was more abundant
and more precocious breast development than in another
similarly treated. He found also that the former had a
greater tendency toward the development of spontaneous
mammary cancer than did the latter. There was also an
apparent relationship between the estrus cycle and the
cancer rate. This finding is part of another phase of
the subject and will be considered later.

r
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Harde (38) confirmed I,acassagne' s work with somewhat less definite results. He also remarked that in

I

mice belonging to strains displaying low tumor rates,
the glands functioned less and the mothers nursed their
young for a shorter time than did those mice belonging

I

to high tumor rate strains where lactation was also
greater. This interesting point brought out by Harde
has not since been confirmed nor has it been discussed
except in relation to the human.
Both Lacassagne and Harde remarked an exaggaration
of e.strus in mice during the precancerous state.
Lacassagne in 1936 (43) reported that in twelve
males given weekly injections of folliculin from the
time of birth, eleven developed adenocarcinoma of the
breast. This he believed significant since males rarely
develop this tumor. Seven of nine sisters of these males,
all of whom were similarly treated, developed tumors
pathologically indistinguishable from those in the males.
In another strain where less than 2% of the females develop spontaneous mammary carcinoma five of six males and
all of four females

~iven

similar injections developed

mammary carcinoma. His series is quite small, but may
be significant in view of the nearly 100% results.
Burrows (13) reported in 1936 because of the rarity
of spontaneous carcinoma mammae in male mice the devel-

rI
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opment of such tumors in two males of one hundred thirty
ordinary mice. These mice had been subjected to the application to the skin of a benzene solution of theelin.
Bonser reported in 1935 (9) and again in 1936 (10)
that she had been studying the effect of weekly injections of ketohydroxyoestrin benzoate in two strains of
mice. The males only were used. In three of nineteen
males of a strain whose females show a high tumo_r rate,
tumors developed. In none of thirty-four males of a
strain of low tumor rate did tumors appear.
Suntzeff and co-workers in 1936 (68) stated that
males are as prone as females to develop carcinoma of
the breast if they are injected with large enough doses
of estrin.
Cramer and Horning (19) reported that tumors appeared in all of five males subjected to application of
oestrin in chloroform to the skin. This confirmed Burrows work.
Gardner and others {35) reported carcinoma in two
of six males under weekly injections of keto-estrin
benzoate.
MacDonald (56) in studying the effects of estrin
and progestin in rabbits failed to find any evidence
suggestive of a production of specific pathologic lesions
of the mammary gland.

,..r
I
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THEORETICAL DISCUSSIOH
Loeb (46, 47) early conceived the idea from his
work that carcinoma of the breast was at least in part
an hereditary condition. This conclusion was drawn from
data which has already been described. He felt also
that the hereditary factor was only a part of the etiology. He believed from his studies on the effects of
non-breeding and of breeding in mice that there must be
in addition to the hereditary predisposition an internal, intrinsic, or endogenous factor which affected the
mammary gland. This he firmly believed to be the ovary.
His idea was that in order for a carcinoma to develop
in the breast there must be, first, an hereditary predisposition, and, second, an ovarian factor. This
theory, of course, obviously explains the absence of
such tumors in the males since only the hereditary
factor was present in them. It also explains the varying tumor rates in pure strains, as he claimed that the
tumor rate is either the product or the sum of the two
factors.
He later altered his conception somewhat (51) to
include as a third factor that of irritation, but he
still held to the idea that neither the ovarian factor
nor the hereditary factor alone can produce carcinoma.
The absence of tumors in the male breast might result

------------
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from one of these things: {l) structural differences
between the male and female breast; {2) absence of effect of pregnancy and/or nursing in the male; (3) absence of direct influence of the ovarian hormone. Of
the three, he felt that the third is the more likely.
In 1924 the conception arose that the hereditary
factor in ma"lll'Ilary carcinoma might be identical with
some inherited differences in the estrus cycle. Loeb
adhered to his previous belief in two separate and distinct factors (52),but it remained until 192? before he
and Genther (54) studied and charted the estrus cycles
of many mice of different strains. They found wide
variations in the characteristics of the cycle in mice
of the same strain as well as in those of other strains,
and concluded that in all probability there is no definite· relation between length of the sexual cycle (the
ovarian factor) and the hereditary tendency to carcinoma.
They added that work must, in the future, look further
than the ovary to find the basis of heredity in cancer.
Bonser (8) in 1935 after similar studies concluded
that there was no connection between the estrus cycle
and what she designated as "a genetic factor" which "inhfbi ts" tumor development. This is really a confirmation
of Loeb's belief stated in a different manner.
Moskop, Burns, Suntzeff, and Loeb (58) in 1935 con-

-----

-------

26

firmed again the absence of correlation between the estrus cycle and heredity in mammary carcinoma. The same
authors reported the same results again in 1936 (12,
67).

The only dissenting opinion is that of Lacassagne
~2), who in 1934 claimed that he was able to demonstrate

a relationship between breast development, cancer rates,
and the estrus cycle. His work would indicate that precocious breast development and a high cancer rate were
associated with a definite type of estrus cycle. This
has not as yet been confirmed.
Cori (17) agreed with Loeb's point of view but added that the organ predisposition to cancer remains latent in the absence of ovarian function but becomes manifest when an amount of ovarian hormone corresponding to
five to thirty estrus cycles has acted on the breast tissue~

He felt, therefore, that the ovarian factor was real-

ly dual in nature·-- first,

i~

produced development of

the breast, and, second, it provided a periodic etimula.tion of the breast tissue.
Murray (59, 60) suggested in 1927 and 1928 that
one possibility might be that the cessation of ovarian
activity after a period of activity was the chief factor in producing mammary cancer. Such a condition is
found in female mice castrated later in life, and in
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their case tumors developed more frequently tha.n they
did in non-breeding females, where there was no cessation of ovarian activity. The accompanying table illustrates this fact.
:Hum'Der used % tumors
207
Non-breeding females
11.5%
17 .ljb
Castrated females
210

usual rate
80%
80%

Gardner (34) disagreed with Loeb and Cori. He
felt that the ovary was responsible for mammary carcinoma only in so far as it developed the breast and
therby furnished a site in which the carcinoma might
develop. His contention was based on the finding that
in males treated either by ovarian transplants or by
estrin injections a duct system comparable to that in
normal virgin females developed. He was unable to obtain tumors in any mice so treated, although all but
three were from susceptible strains.
If it be assumed, then, with Loeb, that for a
cancer to develop in the breast two factors at least
are essential -- namely, an inherited organ predisposition and an ovarian factor -- the second of these
factors should be considered as to the mechanism
underlying its action. This has already been briefly
touched upon, but now the discussion turns to a more
careful consideration of this point.
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Several mechanisms may be presupposed.
(1) According to Gardner (34) the ovarian hormone is a factor only in so far as it develops the
breast.
(2) According to Allen (2) certain localized
areas of mammary ducts may be more sensitive than
others to

sti~ulation

with theelin. This was suggested

by a finding already mentioned in the discussion of
physiology.
(3) According to Lacassagne (44) carcinoma is most
com.man in ducts commonly plugged (breast, sebaceous
glands, sudorific glands, uterine glands, and the prostate) and the retained secretion may contain enough
stagnant estrin to act as a carcinogenic agent. In
favor of this view he called attention to the fact that
colostrum is high in estrin content, and

tha~

in the

human, carcinoma frequently arises out of cystic disease
of the breast.
Further evidence of this effect was given by Bogen
(7) in 1935. By removal of young from the mother mice at
birth there was a tendency for carcinoma to appear in
those breasts which were not suckled. Similar results
were obtained by ligating one nipple and permitting the
opposite one to be suckled.
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i.

Suntzeff, Burns, Moskop, and Loeb (68) could demonstrate no effect on tumor production following ligation
of the ducts, but the experiment was apparently not well
controlled as secretions of the untouched breast were
not removed by suckling.
Fekete and Green (27) performed a similar experiment save tha.t they cauterized one nipple with a hot
wire in place of ligating it. In a high tumor strain of
mice they found that

557~

of tumors which appeared follow-

ing this procedure were in the breast whose nipple was
obliterated. In a low tumor rate strain no tumors appeared in that breast.
A personal communication from Dr. J. H. Schmela regarding the incidence of carcinoma of the mammary gland
in cattle is interesting. In his entire experience of
twenty-five years as a veterinarian he has seen but two
or three cases. The milk ducts of the dairy cow are certainly not allowed to become stagnated.
(4) According to Burrows (14) the effects of estrogens are limited entirely to organs belonging to or
representative of embryologic remnants of the reproductive system. This indicates a specificity of theelin not
possessed by

ot~er

carcinogenic substances. Other authors

described this same specificity (Loeb, 51; Cramer and
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Horning, 19). Burrows in addition described the response
to theelin obtained from such organs. Their epithelium
undergoes apparently the following

changes:~)

arrest

of function, (B) hyperplasia, (C) metaplasia,and ultimate keratinization, and (D) suppuration.
Cramer and Horning (19)

described the hyperplasia

which occurs and labeled it the "precancerous condition".
All the theories so far advanced admit that the
ovarian hormone is concerned in the development of carcinoma of the mammary gland of the mouse. The exact manner
in which this takes place is still a matter for speculation and further investigation and cannot be determined
at the present.
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MAMMARY CARC r.~:ro:M'A IN THE HOJ.!AN

I-

EFFECTS OF

BR..~EDING

Atill LACTATION GN TU1!0R INCIDENCE:

As long ago as 1845 Sir Astley Cooper (16) said:

II
I

I

"Suckling ••• diminishes the disposition to malignant diseases of the breast, for although women
who have had children are still liable to cancerous and fungoid diseases, yet it is undoubtedly
true, that breasts which have been unemployed in
suckling, in women who have been married, but are
childless, and in those who have remained single,
are more prone to malignant diseases than those of
women who have nursed large families • • • If
Lane-Claypon (45) reported in 1926 a statistical
study which was very elaborately worked out. This was a
survey of cases in Glasgow and London hospitals. She
stated:
''the married state and the production of children
far from being conditions favourable to the occurrence of cancer of the breast, are substantially antagonistic to it.

• • • Lactation, even when repeated

in successive pregnancies, does not appear, per se,
to be a circumstance which has influence, one way or
the other, on liability to cancer •••• The breast
which has never been called upon for normal function
is certainly more liable to become cancerous".
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In her studies the women were divided into a can-

I·

cer series and a control or non-cancer series. She found

I

that in her control series as compared with her cancer
series there were on the average (1) an earlier marriage,
(2) an earlier climacteric, (3) a longer mean duration
of marriage before the climacteric, and (4) more children
and fewer miscarriages and stillbirths. The following
chart displays these findings.
CANCER SERIES

263~ COUTROL SERIES 2S5 ~

Means Standard Dev. Means Standard Dev.
e at marriage
3.48
o. of children
marria e 18.56

2.88

8.43

5.34
20.92

3.68

8.10

She found that those women who ultimately developed
carcinoma bore 22% fewer children than the controls (allowing properly for the relative duration of marriage). This
finding would indicate that fertility and low incidence of
breast cancer are related.
She concluded also that any connection between cancer
of the breast and lactation lies in the absence of function or in the excessive use of the breast. Unilateral
lactation does not appear to have any untoward influence
in causing cancer of the breast so used.
Von Winiwarter (??) in an extensive statistical
study in 1878 concluded that the more seldom a woman gave
birth to children the greater were her chances of developing mammary carcinoma.

I
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While the studies described above were made from
individual case records and therefore reflect an accurate
picture of the cases studied, another method of analyzing
large groups of cancer cases was undertaken in 1935 by
Emil Bogen.
He (7) found from his studies of vital statistics
that in those

st~tes

with low birth rate (from females

aged between fifteen and forty-four years at the time
of their delivery) in the year 1900 there was a higher
incidence of deaths from mammary cancer in 1930, among
women over forty-five. The statistics were taken at
this thirty year period to permit women in the childbearing ;,ears in 1900 to reach the cancer age in 1930.
The inverse ratio he described above he found nearly
consistent for all the states, and upon this fact he
based his contention that breast cancer is more common
in those states where the birth rate is low.
A study of vital statistics from countries other
than the United States was made. This revealed a strikingly similar inverse ratio -- with England and Scotland high in death rates from breast cancer and very
low in birth rate. Japan and Chile footed his list with
low breast cancer death rates and high birth rates. However, in studying the material presented by Bogen too
much reliance must not be placed upon data reported by
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countries where registration of births and deaths is
not well kept. Another fault lies in the fact that the
average age at death is not constant in different countries and the possibility therefore exists that in some
places the women develop cancer because they live longer.
However, his study is well worked out and is
interesting from the speculative standpoint. Inasmuch as
it supports previous studies it may be of value.
Thus, it has been found that comparative infertility or sterility is associated with a high incidence of
breast cancer, and that among those women who have borne
and nursed children the cancer rate is considerably lower.
EFFECTS O:B' BREEDING AND LACTATIOU

01~

TU1..!0R GROWTH:

It is important to distinguish between the effects
of pregnancy and lactation on a tumor not yet present
and on one already present and growing.
Trout (72) in 1922 described two cases of women,
aged thirty-two and thirty-four years, each of whom had
had amputation of one breast for carcinoma and both of
whom subsequently became pregnant. About the sixth month
tumors appeared in their remaining breast and grew unusually rapidly.
He reported also receiving letters from sixty-two
surgeons. Of these, forty-six volunteered the informa-
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tion that they had "noticed that pregnancy apparently
stimulated cancer to develop more rapidly no matter
where the growth might be located." In this series of
replies were reported seventeen cases of breast cancer
associated with pregnancy. All of these were seen late

l
I

in the disease, and all went to a rapid and fatal termination. He also found in this series that there had
been fifteen instances when pregnancy occurred after removal of one breast. Of these, thirteen (nearly 89%)
developed carcinoma in the remaining breast and twelve
died very promptly.
In 1934 Farati (26) described six cases of breast
carcinoma in his clinic which were coincident with pregnancy or with lactation. He did not present details of
these cases, but he concluded from his experience that
the malignancy of breast cancer is markedly increased by
either of these conditions.
In 1936 Schockaert (62) reported the cases of two
females with mammary carcinoma who became pregnant. In
both, the neoplasms grew unusually rapidly.
The frequency of carcinoma occurring in the second
breast after amputation of the first has been investigated by Kilgore (41). In 1921 he stated that:
"the patient who has had one breast amputated for
cancer is, if she survives five years, from three to
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four times more likely to develop cancer in the second breast than a normal woman of the same age in
either of her two breasts."
His description also told that he felt that the tumor appeared to be primary in each breast although in some

I
J
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cases it might have been metastatic. This he felt suggested a "cancer diathesis".

~i

Emge (24) reviewed the literature pertaining to the
effects of pregnancy on tumor growth. He found that an
inhibitory effect on tumors in general was commonly described. However, he concluded that neoplastic tissue
sensitive to hormonal stimuli may exhibit increased
activity during pregnancy. He reported one case of breast
carcinoma which:1had been previously treated by breast
amputation and by X-ray. This patient developed a recurrence

during a pregnancy. There was rapid metastasis,

premature delivery, and death by the sixth month from a
generalized carcinomatosis.
With this evidence it may be concluded then that in
women who become pregnant after having had one breast removed for cancer, there is grave danger of it appearing
in the other breast. This may be due to the fact that
pregnancy seems to stimulate the growth of breast malignancies, and this effect may well be expected from the
normal physiological stimulation of the breast during
pregnancy.
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EFF.l:;;CTS OF OVARIECTOMY:

It is, of course, impossible to use ovariectomy in
the human as an experimental means of studying cancer of
the breast. However, in 1896, Beatson (5), an English
surgeon, suggested on the basis of some observations
which he had made that

o~phorectomy

might possibly be of

benefit in treating a cancer of the breast. He used this
method in two cases and reported the patients "cured".
Alexis Thomson

(71) followed Beatson's ideas and

analyzed eighty cases in which there had been used this
sort of therapy. He found eighteen cases in which there
was decided improvement and some regression of the tumors.
Eleven cases showed less improvement, and fifty-one showed
no appreciable change in the course of the disease.
CARC DIOMA OJ!, THE MALE BREAST:

It has been generally conceded that carcinoma of the
male breast is a rare occurrence. Just how rare it is is
shown by reference to the Mortality Statistics for the
United States (75). Below is listed the number of deaths
from cancer of the breast for several years' time.
MAI.E

FEMALE

YEAR

White

1934
1933
1932

150

11

145
171

21
17

Negro

White
12,220
11,516
10,905

}.Tegro
768
766
710

-
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Obviously there is a marked difference in the
i.

incidence of this disease between the two sexes. Just
what is the reason for this?
Of course the suggestion at once occurs to the
investigator that the reason is the lack of breast development in the male. This, however, must remain
speculative, as experimental studies on the human being
are seldom permitted.
However, occasionally a male breast does develop.
This condition is referred to as gynecor.iastia. The occurrence of this in itself is rare. \'/hen it does appear it
is usually unilateral.
According to Geschickter, Lewis and Hartman (36)
gynecomastia occurs most frequently in males of the

l
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white race between the ages of thirty and forty years.
These men stated that the lesion is more frequently unilateral than bilateral, and in their series it occurred
about

just as frequently as ·carcinoma of the male

breast. However in no case of gynecoTiastia did they find
evidence of malignancy at any time.
Cheat le and Cut le~ ( 15) ata.ted that the development
of carcinoma in a breast which is the seat of gynecomastia
has been recorded, but it is so rare that the event may
be regarded as a coincidence rather than as an example of
etiological relationship.
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Thus although an occasional male breast does reach
'' .

a "virginal" stage of development (so described by Geschickter, 36) the incidence of cancer in such breasts
is low enough to eliminate the suspicion that the cause
of the gynecomastia and the cause of the carcinoma of
the breast are identical.
ESTROGE:N"IC HORJJO}ffi

r~r

THE FEMALE:

The following discussion deals with the occurrence
of the estrogenic hormone in the human female.
Allen and Daisy (3) in a preliminary report on an
ovarian hormone in 1923 described the isolation and partial purification of the ovarian follicular hormone.
Therebyarose the search for its presence in other organs
in the body and for its presence in excreta and secreta.
Before their discovery, Stockard and Papanicolaou
(66) in 1927 described changes in the vaginal fluid of
the guinea pig during various phases of its estrus eyele. Although they failed at the time to realize the value
of this finding from the standpoint of its later use as
a test for follicular hormone, such became the case. At
present when follicular hormone is being tested for,
virgin castrated female animals are used and the preparation being examined is injected. The vaginal fluid then
reveals whether the fluid injected contained theelin or
not, for theelin causes a disappearance of leucocytes

~T

I]

from the vaginal smear and produces a desquamation of

1

keratinized cells in their place. Utilizing this method

l'
i
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many interesting findings have been uncovered.
In 1930 Dingemanse, Freud, de Jongh, and Laqueur
(20) were struck by their finding that in twenty-nine
persons, all of whom had a carcinoma, very high quantities (up to 10,000 M. U. per liter) of menformon
(follicular hormone) were found in the blood. They gave
no details of the cases and drew no conclusions.
In 1932 Loewe, Raudenbusch, and Voss (55) told of
Dingemanse's work and stated that Zondek in 1931 was unable to confirm this. They analyzed non-genital carcinomata of males and found 125 ld. U. of female sex hormone per kilogram of tissue.
Frank (28) in 1934 described the normal content of
female sex hormone in the blood. His figure was 1 M. U.
per twenty cubic centimeters of blood. This he said is
the maximum normal amount. In the urine there may be as

'
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high as 10,600 units per liter {as in pregnancy or dur-

Jl

ing ovarian hyperfunction). He stated that he had found

1

by this method that even after the menopause cyclical

l

Il

'l

l

ovarian activity may continue for years. This is, of
course, slightly diminished. In some cases it is, however, completely abolished.
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He further described the normal findings in the
blood and urine in 1934 (33) and in 1935 (29). The sex
endocrine principles have been demonstrated in the placenta, in bile, sweat, saliva, and in cerebrospinal
fluid. The estrogenic principle circulates each month in
ever increasing concentration until the onset of menstruation when there is a marked drop. There is with
this increasing secretion an increasing curve of urinary
excretion.
During pregnancy a higher level of the estrogenic
factor is noted in the blood after the eighth week, and
there is a dis-pro-portionately greater increase in the
quantities excreted in the urine.
After the menopause for as long as two years he has
been able to demonstrate estrogenic factor both in the
blood and in the urine.
Frank, Goldberger, Salmon, and Friedman (32) described the finding of large amounts of estrogenic factor
varying from 800 to 8000 l.{. U. per kilogram in the psoas
muscle of four normal cyclical females. On the basis of
this finding they warned against basing conclusions on
the mere presence of estrogenic factor in abnormal tissues unless it should later be shown {which as yet has
not been done) that estrogenic factor is not widely
distributed throughout the body of the human female.
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In 1936 Frank, Goldberger, and Salmon (31) told
of finding that the estrogenic factor continues to be
excreted after surgical removal of the ovaries as well
as after the physiological menopause. The same is
found true after X-ray C8.stration.

~.Jo

satisfactory ex-

planation of the source of this estrogenic principle
has been offered.

1
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TH.EORETICAL DISCUSSION
In turning to a consideration of

t~e

relationship

of breast cancer and theelin certain facts must be correlated. These are listed as briefly as possible in the
following table.
PROCEDURE

EXPERlK~~TAL

ANIWi.AL

Breeding &
Lactation

Increases tumor incidence
Lowers tumor age

Pregnancy

Decreases tumor growth

Ovariectom.y

Decreases tumor incidence
Raises tumor age
Decreases tumor incidence

Radiation
castration
Injection of Produces CA in male or f emale of susceptible strains
folliculin
Incidence in Very rare
males

IiUMAN
Decreases
incidence
Speeds
growth
promotes
involution
:promotes
involution
Dangerous?
1 in about

100 cases

Any satisfactory explanation must, therefore, take
into consideration the diametrically opposed findings
in regard to the effects of breeding and lactation. This
finding alone is so difficult to explain that it is sufficient cause for giving up any attempt at explanation
on the basis of our present knowledge.
But this is not the only obstacle present. Other
points which require explanation are: the rarity with
which carcinoma appears in a male breast which is the
seat of gynecomastia; the fact that in a considerable
number of women cancer does not appear until many years

··rwir···
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after the menopause; the fact that the bearing of children seems to exert a prophylactic effect against the
development of cancer of the breast.
Certainly no one theory so far advanced can explain
satisfactorily all these points. There have been already
presented in connection with the discussion regarding
tumor incidence in mice several theories.
The first of these considered the ovarian hormone
a factor only in so far as it developed the breast. This
is of course inconsistent with the observations in gynecomastia.
The second suggested that certain portions of breast
tissue might be more susceptible than others to stimulation with theelin. This of course offers an explanation
only for the pathogenesis.
The third of these was suggested by the !requency
with which cancer occurs in glands whose ducts commonly
become plugged. This stagnation theory has been taken up
by several -- even in the pseudo-scientific manner of
the lay press (Walter Martin in Coronet, 57). Lacassagne
(44) hinted that estrin secreted into the ducts thus
blocked might be the causative factor. He called attention in support of this suggestion to the high estrin
content in colostrum. Others claimed other agents as the
carcinogenic one. Bogen (7) suggested that reduced

r·
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derivatives of cholesterol (which were shown to be carcinogenic by Kennaway and Sampson, 40) formed in the stagnant secretions could be responsible. It is well known
that milk contains a considerable quantity of cholesterol
(Ansbacher and Supplee, 4). Lacassagne further called
attention to the frequency with which cancer arises out
of cystic disease of the breast. Geoffrey Bourne (11)
called attention to the fact that there is a close
relationship between the cancer age (which he designates
as forty to sixty years) and the alteration in the sterol metabolism (evidP-nced by arteriosclerosis and other
changes). He concluded, provisionally, that cancer research in the future will depend on research among the
sterols.
The specificity of the carcinogenic power of theelin
hHs been alluded to by many. This property should be expected from its physiological action upon the tissues related to the genital system.
Ahlborn (1) modified Wintz's views to sa.y that even
though theelin may have no direct carcinogenic effect,
certainly its action in producing a periodic hyperemia
and activity in the breasts during pregnancy and lactation
and during the monthly cycle must be considered, at the
very least, predisposing to the appearance of a cancer or
distinctly dangerous to one already present.

I
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PRACTICAL CONSIDERATIONS

In 1889 Schinzinger (61) propounded a theory upon
which he hoped to base a treatment for carcinoma of the
breast. This theory was developed following observations
upon women who had for various reasons had bilateral
oBphorectomies. He noted the cessation of the menses,
the withering B.nd atrophy of the breasts. He knew the
greater malignancy of carcinoma of the breast which develops during the child-bearing era. Thus has idea was
to make the woman "old" while she was still young -- in
other words remove her ovaries and precipitate an unusually early climacteric.
This plan of his he redescribed in 1905 (61) nine
years after the British surgeon Beatson had suggested a
similar idea. At that time he reported four cases in
women between the ages of thirty and forty. In these
cases there was rapid metastasis, recurrence, ulceration, and death despite a mammectomy. In several others
past the menopause life was prolonged for many years
after the mammectomy. He reported, however, no results
from treatment following his plan.
Beatson in 1896 (5) suggested independently that
women suffering from carcinoma of the breast be subjected to extirpation of their ovaries. His reasoning was
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based on a different belief, however, as he felt that
carcinoma of the breast was partly dependent upon an
abnormal ovarian function. He reported two cases treated by castration as cured. They were undoubtedly at
least alleviated.
In 1902 (5a) he described the indications for oephorectomy as requiring that the woma.n be still menstrua,ting and that she have an absence of metastases in the
viscera or bones.
He felt also that the thyroid had an action on the
breast which antagonized that of the ovary. Consequently
he also used thyroid gland extract ten grains, twice
daily, in addition to the oephorectomy and the local
treatment of the breast by amputation.No other investigators lB.ve confirmed his belief in thyroid, nor has it
been used in this way since.
Alexis Thomson (71) was one of those to follow
Beatson's lead. In 1902 he reported an analysis of cases
treated by

ma.m,~ectomy

and oBphorectomy. In eighteen there

was decided improvement, and life was prolonged for more
than twelve months. In eleven cases there was decided improvement but life was not prolonged for twelve months.
There were fifty-one cases with no appreciable change in
the course of the disease. He concluded from his study·
that the beneficial results following oephorectomy are
sufficiently established to eliminate any question of
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coincidence or of error in diagnosis. He revised the
indications for the procedure to say that (1) it is
not contraindicated by the previous occurrence of the
physiological menopause; (2) it is contraindicated by
the presence of metastases in viscera or bones.
Lett (50) in 1905 reported an analysis of nintynine cases of carcinoma of the breast treated by

o~-

phorectomy in addition to local treatment. Of these,
23.2% showed very marked improvement; there was distinct improvement in thirteen others. If he omitted all
cases over fifty years of age, seventy-five remained,
and of these 29.3% showed very marked improvement;
there was found distinct improvement in nine others.
He obtained no "cures" with one possible exception.
He noted that the improved condition lasted for a
period which varied from one to five years.
Following these observations removal of the ovaries
in breast carcinoma enjoyed a vogue for quite a period
of time, but with the advent of X-ray and the discovery
that it could be used to produce an artificial menopause
and thereby obviate the dangers of a major operation,
the popularity of surgical castration began to wane.
Foveau de Courmelles was apparently the first to
use X-ray in castration for carcinoma of the breast. He
began its use for this purpose in 1904 and from time to
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time reported results. In 1926 (18) he discussed the question of dosage of X-ray necessa.ry to produce cessation of
ovarian function, and told that it v.-•ried with individual
cases and that he himself varied it tentatively. He described none of the results obtained, but his technique
included X-rRy of the breasts and metastases as well as to
the ovaries, and so the results were not well controlled.
Hugo Ahlborn (1) in 1930 described a series of onehundred sixty-three cases treated in three different ways.
Some received X-ray only to the ovaries, some to both the
tumor, metastases, and the ovaries, and some only to the
tumor and its metastases. From this controlled series he
was unable to obtain statistical evidence of beneficial
effect from the use of ovarian irradiation, unless he
eliminated from his series all those women who were more
or less debilitated before treatment was given.
As dosage, he used the following factors: a

sup~r

ficial dose of 2/3 to 1 SED at focal distance 30 to 40
cm. with a filter consisting of .5 mm. of copper and 1 mm.
of aluminium. This was given over two anterior fields each
12 x 12 ems. and one common back field 20 x 20 ems. The
treatment was given in the course of three days. Current
used was 6 mA., and the voltage was 160 kilovolts. By this
means an active dose at least
e8ch ovary.

40~

SED was delivered to
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In 1933 Hoffman (39) reported a case in which there
had been metastases in the scalp, chest and pelvis. By
the use of heavy doses of X-ray to the pelvis (primarily
directed at metastases there) he found that following
the cessation of the menses the scalp metastases disappeared. The patient improved considerably and gained
in weight and strength following this castration. Metastases present in the liver, however, apparently progressed.
The dosage he used he described as follows: 200
kilovolts, 4 mA., 50 cm. target-skin distance, given
over four portals, 800 r units to each field. The time
he gave as 75 minutes.
Taylor (69) discussed the general topic of "Artificial Menopause in Carcinoma of the Breast''. He summarized in very good fashion the present day beliefs in
regard to this subject very much as follows:
0

Patients with inoperable and recurrent carcinoma

of the breast may be benefitted by radiation castration. Younger patients may be expected to respond
rnor8 favourably.
"Radiation castration following radical operation
may inhibit or postpone the development of metastases.
"Subsequent pregnancy involves a grave hazard of
recurrence
activatingl\of of stimulg,ting development of primary

r
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carcinoma of the second breast and should not be permitted. In the cases who refuse radiation castration,
simple mastectomy of the remaining breast should be
considered.
"The treatment of operable carcinoma of the breast
complicRted by pregnancy should include prompt abortion. 11
With this last statement McGoogan is in almost complete accord. In a. consideration of bone tumors complicateiiby pregnancy, (al) ,yet unpublished, he will state that
abortion is indicated in carcinoma of the breast where
there are no bone metastases. He believes that abortion
is of no value in saving the mother in such an event.
Witherspoon (78) in 1936 advanced the hypothesis
that in patients with carcinoma of the breast whether it
be primary or secondary, operable or inoperable, recurrent or metastatic, all ovarian activity should be destroyed by means of high voltage radiation by Roentgen
ray.
Dresser (22) described his feelings in the matter,
pointing out that carcinoma of the breast in a young
woman is usually more malignant than in women who have
passed the menopause; that it runs a more rapid course
and ands fatally in a large percentage of cases regardless of all known therapeutic measures. He emphasized
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the fact that pregnancy may cause an exacerbation of
malignancy of the breast with an unusually rapid progress of the disease. He stated that an operable carcinoma is rarely observed late in pregnancy.
He reported a series of thirty pre-menopausal
women with carcinoma treated by means of ovarian irradiation with remission of symptoms and regression of
metastases in 30%.
On the basis of this he recommended routine examination of bones, lungs, etc. for metastases. If they
are found absent he advised the procedure be radical
mastectomy followed by ovarian irradiation if the woman
is not past the menopause. If metastases are present he
advised radiation to the breast, to the metastases, and
to the ovaries.
Trout (72) in 1922 confirmed a belief that surgeons should warn their patients who are in the childbearing era and from whom a carcinoma of the breast has
been removed, not to become pregnant for fear of serious
trouble in the remaining breast.
Schockaert (62) sounded a similar warning note, adding that a woman suffering from or cured of carcinoma or
any pre-cancerous lesion should never be given theelin
for therapeutic purposes.
Steel

(65) in 1936 described the results of X-ray
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castration as follows: (1) disappearance of pain, (2)
return to good health, (3) recalcification of bony
lesions, (4) no relief from further or local radiation
after recurrence, and (5) rapid death after recurrenceHe emphasized the value of X-ray castration in relieving the patient's symptoms for a variable time, and
the rapid death of the patient which follows upon recurrence, he considered highly desirable as it relieved
the prolonged bed-ridden stage of the untreated disease
which causes so much grief to the patient, her family,
and her doctor.
He reiterated the warning that further pregnancies
should be avoided and that any woman under fifty who develops carcinoma. should be immediately sterilized by the
use of X-ray.
Dr. H. B. Hunt in a personal communication discussed
the value of X-ray castration of the female suffering
from breast cancer as a palliative means. He told of relief from pain and other distressing symptoms which is
quite spectacular, following this treatment. He has had
experience with it personally at the University Hospital
and at Mebraska Methodist Hospital. The use of X-ray,
however, is not limited to the ovaries in his technique,
but is directed also against the metastases and the primary tumor if surgery has not been used. He told of a
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feeling that irradiation castration has a definite place
in the therapy of breast cancer.
He reported a personal communication from Dr.

c.

C.

Little who has been working with irradiation castration
of mice. He found that such treatment of females of
strains with a high incidence of spontaneous mammary
carcinoma markedly lowered this incidence. His work is
as yet unpublished.
The therapeutic use of theelin in various gynecologic disorders has been frowned upon by editorials appearing in medical journals (23, 30). For that reason
a discussion follows as to the dangers, if a.ny, attendant upon its use.
Schockaert (62) in 1935 emphatically declared that
theelin should never be given to a woman suffering from
or cured of cancer or any pre-cancerous lesion. This of
course on the basis of our present feeling in the matter
does constitute a definite contraindication to the use
of theelin.

E.

c.

Dodds (21) in 1935 was skeptical of the carci-

nogenic power ascribed to theelin. He felt that "an extensive search of the literature fails to reveal any incontrovertible evidence that the estrus-producing hormone is carcinogenic".
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Hans Guggisberg (37) stated that while· there is
some evidence to show that some of the hormones underlie the development of certain kinds of tumors, the
surface of this field has hardly yet been scratched.
Cramer and Horning (19) felt that theelin does
exert a carcinogenic effect, but they called attention to the fact that ir. mice intensive therapy must
be e;i ven for a long time in order to p:-oduce care inoma.
This period constitutes seven to ten years of a human
life. :-re concluded that since no such active therapy as
this is used in the human no alarm need be felt.
Nevertheless editorial comment warns aga.inst the
use of large doses of estrogenic substances until further study establishes definitely their role. Estrin
therapy should be withheld in patients with definite or
possible susceptibility to tumors (23).
Frank, speaking editorially in the American Journal
of Obstetrics and Gynecology (30) stated that the evidence
of the estrogenic properties possessed by carcinogenic
agents and the close resemblance chemically between these
carcinogenic agents and the sex hormones is of extreme
theoretical interest and no more.
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1 Because of recent warnings appearing in the literature against the therapeutic use of estrogenic substances and because of their similarity to carcinogenic substances found in tar, this subject has been
investigated.
2 There is evidence that theelin is very similar chemically to pure substances isolated from coal tar and
known to be carcinogenic.
3 Theelin, the follicular hormone, is responsible for
proliferation of the ducts of the mammary gland, but
requires the

co~peration

of progestin to produce al-

veolar proliferation.
4 It has been found possible to decrease the incidence
of mammary carcinoma in mice by prevention of breeding or by surgical or X-ray castration. Breeding increases the incidence.
5 An opposite effect was found possible by the injection of theelin

tumors appeared even in males

thus treated.
6 In the human, pregnancy or lactation increase markedly the malignancy of breast cancer, and relative
infertility or sterility is found to be associated
with a higher incidence of breast cancers.
7

O~phorectomy

has been used in treating breast can-

5?
cers in women not yet at the menopause. At present
X-ray castration is widely used.
8 Indications for X-ray castra.tion are : (1) breast
cancer in a woman not yet at the menopause, (2)
opera.ble or inoperable breast ca.ncer.
9 Pregnancy is contraindicated by breast cancer, and
if it occurs therapeutic abortion should be done,
unless bony metastases are already present.
10 Women with breast cancer or any pre-cancerous lesion
should not receive therapeutic injections of theelin
or any of its related preparations.
ll There is no other contraindication to the use of
theelin provided it is not given in massive doses
nor over a prolonged period.
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